Aquestive Therapeutics, Inc. - AQST
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Oct 07, 2026 | SCHEDULE 13G | Bass Edward P | 7.5% | 9,385,561 | View |
| Oct 07, 2026 | SCHEDULE 13G | THRU LINE L.P. | 6.3% | 7,876,267 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | BRATTON DOUGLAS K | 0.6% | 691,873 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | MonoLine RX II, L.P. | 0.0% | 0 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | MonoLine RX III, L.P. | 0.0% | 0 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | MonoLine RX, L.P. | 0.0% | 0 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | MonoLine Partners, L.P. | 0.0% | 0 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | MonoSol Rx Genpar, L.P. | 0.0% | 0 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | Bratton Capital Management, L.P. | 0.3% | 390,795 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | Bratton Capital Inc. | 0.3% | 391,670 | View |
| Oct 07, 2026 | SCHEDULE 13G/A | Bratton Family Partners L.P. | 0.0% | 33,727 | View |
| Jul 27, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 6.4% | 7,992,647 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.